Blurred Lines: Sponsor Role In FSD Patient Meeting Questioned
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
At FDA’s female sexual dysfunction meeting, industry faces criticism for sponsoring patients to attend and backing a marketing campaign that calls for equality in approvals of drugs for male and female dysfunction.